Back to Journals » Vascular Health and Risk Management » Volume 5

Vascular Health and Risk Management


Archive: Volume 5, 2009

Nitric oxide and coronary vascular endothelium adaptations in hypertension

Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al

Vascular Health and Risk Management 2009, 5:1075-1087

Published Date: 16 December 2009

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea

Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al

Vascular Health and Risk Management 2009, 5:1063-1073

Published Date: 11 December 2009

Persistent high fever and systemic inflammation induced by percutaneous coronary intervention-related periaortitis

Takamori Kakino, Tomohiro Nakayama, Hideo Yamamoto

Vascular Health and Risk Management 2009, 5:1059-1062

Published Date: 8 December 2009

Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence

Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al

Vascular Health and Risk Management 2009, 5:1015-1031

Published Date: 18 November 2009

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al

Vascular Health and Risk Management 2009, 5:1007-1014

Published Date: 20 November 2009

Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo

C Makena Hightower, Joyce D Hightower, Beatriz Y Salazar Vázquez, et al

Vascular Health and Risk Management 2009, 5:1001-1005

Published Date: 17 November 2009

Vascular health in children and adolescents: effects of obesity and diabetes

Kevin R Short, Piers R Blackett, Andrew W Gardner, et al

Vascular Health and Risk Management 2009, 5:973-990

Published Date: 10 November 2009

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting

Rakesh K Sharma, Hanumanth K Reddy, Vibhuti N Singh, et al

Vascular Health and Risk Management 2009, 5:965-972

Published Date: 9 November 2009

The treatment of diabetic foot infections: focus on ertapenem

Michael Edmonds

Vascular Health and Risk Management 2009, 5:949-963

Published Date: 6 November 2009

Comparative assessment of angiotensin receptor blockers in different clinical settings

Paolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al

Vascular Health and Risk Management 2009, 5:939-948

Published Date: 6 November 2009

Erratum

Zeina AR, Slobodin G, Naschitz JE et al.

Vascular Health and Risk Management 2009, 5:937-938

Published Date: 3 November 2009

Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea

Sanja Jelic,  David J Lederer, Tessa Adams, et al.

Vascular Health and Risk Management 2009, 5:909-920

Published Date: 3 November 2009

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes

Nikolaos Östlund Papadogeorgos, Mattias Bengtsson, Majid Kalani

Vascular Health and Risk Management 2009, 5:893-899

Published Date: 28 October 2009

Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control

Dion Zappe, Cheraz Cherif Papst, Philippe Ferber, et al.

Vascular Health and Risk Management 2009, 5:883-892

Published Date: 22 October 2009

Treatment of congenital fibrinogen deficiency: overview and recent findings

Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al

Vascular Health and Risk Management 2009, 5:843-848

Published Date: 5 October 2009

Ankle Brachial Pressure Index (ABPI): An update for practitioners

Mo Al-Qaisi, David M Nott, David H King, et al

Vascular Health and Risk Management 2009, 5:833-841

Published Date: 30 September 2009

Update on the clinical use of the low-molecular-weight heparin, parnaparin

Giuseppe Camporese, Enrico Bernardi, Franco Noventa

Vascular Health and Risk Management 2009, 5:819-831

Published Date: 25 September 2009

Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice

Cláudia Maria Vilas Freire, Antonio Luiz Pinho Ribeiro, Felipe Batista Lima Barbosa, et al

Vascular Health and Risk Management 2009, 5:811-817

Published Date: 24 September 2009

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy

Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, et al

Vascular Health and Risk Management 2009, 5:801-810

Published Date: 21 September 2009

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy

Vascular Health and Risk Management 2009, 5:793-799

Published Date: 21 September 2009

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation

Gerald V Naccarelli, Frank Peacock

Vascular Health and Risk Management 2009, 5:783-791

Published Date: 11 September 2009

Protein C preserves microcirculation in a model of neonatal septic shock

Doris Fischer, Marcel F Nold, Claudia A Nold-Petry, et al

Vascular Health and Risk Management 2009, 5:775-781

Published Date: 10 September 2009

Antiatherogenic effects of vitamin E: the search for the Holy Grail

Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2009, 5:767-774

Published Date: 10 September 2009

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

Jesús Millán, Xavier Pintó, Anna Muñoz, et al

Vascular Health and Risk Management 2009, 5:757-765

Published Date: 10 September 2009

HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men

Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Vascular Health and Risk Management 2009, 5:751-756

Published Date: 8 September 2009

Pattern of heart failure in a Nigerian teaching hospital

Arthur C Onwuchekwa, Godspower E Asekomeh

Vascular Health and Risk Management 2009, 5:745-750

Published Date: 7 September 2009

Metabolic syndrome and cardiovascular disease in South Asians

Danny Eapen, Girish L Kalra, Nadya Merchant, et al

Vascular Health and Risk Management 2009, 5:731-743

Published Date: 3 September 2009

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study

Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al

Vascular Health and Risk Management 2009, 5:723-729

Published Date: 27 August 2009

Cardiovascular disease in patients with chronic kidney disease

Julian Wright, Alastair Hutchison

Vascular Health and Risk Management 2009, 5:713-722

Published Date: 26 August 2009

Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study

Ramona S DeJesus, Rajeev Chaudhry, Dorinda J Leutink, et al

Vascular Health and Risk Management 2009, 5:705-711

Published Date: 24 August 2009

Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study

Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al

Vascular Health and Risk Management 2009, 5:673-676

Published Date: 11 August 2009

RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension

Scott A Barman, Shu Zhu, Richard E White

Vascular Health and Risk Management 2009, 5:663-671

Published Date: 9 August 2009

Validation of reported physical activity for cholesterol control using two different physical activity instruments

Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al

Vascular Health and Risk Management 2009, 5:649-661

Published Date: 6 August 2009

Dronedarone for atrial fibrillation: a new therapeutic agent

Pawan D Patel, Rohit Bhuriya, Dipal D Patel, et al

Vascular Health and Risk Management 2009, 5:635-642

Published Date: 5 August 2009

Should embolectomy be performed in late acute lower extremity arterial occlusions?

Hikmet Iyem, M Nesimi Eren

Vascular Health and Risk Management 2009, 5:621-626

Published Date: 31 July 2009

Irbesartan improves arterial compliance more than lisinopril

Khalid Ali, Chakravarthi Rajkumar, Francesco Fantin, Rebekah Schiff, Christopher J Bulpitt

Vascular Health and Risk Management 2009, 5:587-592

Published Date: 13 July 2009

Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension

Martin Thoenes, Jan-Christian Reil, Bobby Varkey Khan, Peter Bramlage, et al.

Vascular Health and Risk Management 2009, 5:577-585

Published Date: 13 July 2009

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Vascular Health and Risk Management 2009, 5:567-575

Published Date: 2 July 2009

Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome

Marco Matteo Ciccone, Stefano Favale, Anish Bhuva, Pietro Scicchitano, et al.

Vascular Health and Risk Management 2009, 5:561-566

Published Date: 25 June 2009

The role of insulin detemir in overweight type 2 diabetes management

Yared N Demssie, Naveed Younis, Handrean Soran

Vascular Health and Risk Management 2009, 5:553-560

Published Date: 29 June 2009

Pleiotropic effects of statins in atrial fibrillation patients: the evidence

Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham

Vascular Health and Risk Management 2009, 5:533-551

Published Date: 17 June 2009

Histopathologic changes of the radial artery wall secondary to transradial catheterization

Cezar S Staniloae, Kanika P Mody, Kintur Sanghvi, Catalin Mindrescu, et al.

Vascular Health and Risk Management 2009, 5:527-532

Published Date: 23 June 2009

Treatment of pediatric pulmonary hypertension

Amy Hawkins, Robert Tulloh

Vascular Health and Risk Management 2009, 5:509-524

Published Date: 3 June 2009

Reducing morbidity and mortality in high risk patients with statins

Vibhuti Singh, Prakash Deedwania

Vascular Health and Risk Management 2009, 5:495-507

Published Date: 5 June 2009

Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian

Vascular Health and Risk Management 2009, 5:489-494

Published Date: 27 May 2009

Hematocrit and mean arterial blood pressure in pre- and postmenopause women

Beatriz Y Salazar Vázquez, Miguel A Salazar Vázquez, Marcos Intaglietta, Ulf de Faire, et al.

Vascular Health and Risk Management 2009, 5:483-488

Published Date: 25 May 2009

Inhaled iloprost for the control of pulmonary hypertension

Sabine Krug, Armin Sablotzki, Stefan Hammerschmidt, Hubert Wirtz, Hans-Juergen Seyfarth

Vascular Health and Risk Management 2009, 5:465-473

Published Date: 19 May 2009

The use of sibutramine in the management of obesity and related disorders: An update

Konstantinos Tziomalos, Gerasimos E Krassas, Themistoklis Tzotzas

Vascular Health and Risk Management 2009, 5:441-452

Published Date: 14 May 2009

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials

Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia

Vascular Health and Risk Management 2009, 5:411-427

Published Date: 8 May 2009

Safety and efficacy of alteplase in the treatment of acute ischemic stroke

Giuseppe Micieli, Simona Marcheselli, Piera Angela Tosi

Vascular Health and Risk Management 2009, 5:397-409

Published Date: 8 May 2009

Safety and efficacy of rosiglitazone in the elderly diabetic patient

Adie Viljoen, Alan Sinclair

Vascular Health and Risk Management 2009, 5:389-395

Published Date: 30 April 2009

Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial

Ming-Sheng Zhou, Ivonne Hernandez Schulman

Vascular Health and Risk Management 2009, 5:361-368

Published Date: 16 April 2009

Arterial stiffness, hypertension, and rational use of nebivolol

Enrico Agabiti-Rosei, Enzo Porteri, Damiano Rizzoni

Vascular Health and Risk Management 2009, 5:353-360

Published Date: 19 May 2009

Efficacy and safety of rosuvastatin in the management of dyslipidemia

Paolo Rubba, Gennaro Marotta, Marco Gentile

Vascular Health and Risk Management 2009, 5:343-352

Published Date: 7 April 2009

Prasugrel for the treatment of patients with acute coronary syndrome

Filippo Marzot, Vittorio Pengo

Vascular Health and Risk Management 2009, 5:321-324

Published Date: 6 April 2009

Prevention of atherosclerosis in patients living with HIV

Ferruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, Brian Gazzard, John L McGregor, Kevin Shotliff, Han Xiao

Vascular Health and Risk Management 2009, 5:287-300

Published Date: 26 March 2009

Corrigendum

Dove Medical Press Editorial

Vascular Health and Risk Management 2009, 5:273-274

Published Date: 18 March 2009

Candesartan cilexetil in the treatment of chronic heart failure

Jean-Philippe Baguet, Gilles Barone-Rochette, Yannick Neuder

Vascular Health and Risk Management 2009, 5:257-264

Published Date: 4 March 2009

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction

Giovanni Melandri, Fabio Vagnarelli, Daniela Calabrese, Franco Semprini, Samuele Nanni, Angelo Branzi

Vascular Health and Risk Management 2009, 5:249-256

Published Date: 26 February 2009

The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man

Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli

Vascular Health and Risk Management 2009, 5:233-242

Published Date: 8 February 2009

Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review

Steve Fordan, Philip Raskin

Vascular Health and Risk Management 2009, 5:225-231

Published Date: 19 February 2009

Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis

R J M W Rennenberg, A G H Kessels, L J Schurgers, J M A van Engelshoven, P W de Leeuw, A A Kroon

Vascular Health and Risk Management 2009, 5:185-197

Published Date: 22 January 2009

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study

JP Baguet, R Asmar, P Valensi, S Nisse-Durgeat, JM Mallion

Vascular Health and Risk Management 2009, 5:175-183

Published Date: 21 January 2009

The management of gestational diabetes

N Wah Cheung

Vascular Health and Risk Management 2009, 5:153-164

Published Date: 15 January 2009

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study

Prasad Bichu, Ravi Nistala, Asma Khan, James R Sowers, Adam Whaley-Connell

Vascular Health and Risk Management 2009, 5:129-140

Published Date: 22 December 2008

Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

Odd Erik Johansen, Pål Johan Vanberg, Bente Kvarv Kilhovd, Anders Palmstrøm Jørgensen

Vascular Health and Risk Management 2009, 5:121-128

Published Date: 18 December 2008

Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization

Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté

Vascular Health and Risk Management 2009, 5:101-119

Published Date: 11 January 2009

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial

Nader Nouri-Majalan, Reza Nafisi, Sarasadat Moghadasi-Mousavi

Vascular Health and Risk Management 2009, 5:97-100

Published Date: 10 December 2008

The independent relationship between triglycerides and coronary heart disease

Alan Morrison, John E Hokanson

Vascular Health and Risk Management 2009, 5:89-95

Published Date: 23 October 2008

Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women

Asha A Gader, Abed Elrahium D Haggaz, Ishag Adam

Vascular Health and Risk Management 2009, 5:85-87

Published Date: 4 December 2008

Differential expression of Gs in a murine model of homocysteinemic heart failure

Thomas P Vacek, Utpal Sen, Neetu Tyagi, Jonathan C Vacek, Munish Kumar, et al

Vascular Health and Risk Management 2009, 5:79-84

Published Date: 4 December 2008

Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors

Divina G Brillante, Anthony J O’Sullivan, Laurence G Howes

Vascular Health and Risk Management 2009, 5:73-78

Published Date: 4 December 2008

Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein

Miguel Arturo Salazar, Vázquez, Beatriz Yadira Salazar, Vázquez, M Intaglietta, Pedro Cabrales

Vascular Health and Risk Management 2009, 5:65-72

Published Date: 30 September 2008

Current management of type B aortic dissection

T Paul Tran, Ali Khoynezhad

Vascular Health and Risk Management 2009, 5:53-63

Published Date: 10 October 2008

Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples

Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, et al

Vascular Health and Risk Management 2009, 5:45-52

Published Date: 7 December 2008

Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?

Mahsa Mohammadi, Inger Ekman, Maria Schaufelberger

Vascular Health and Risk Management 2009, 5:13-19

Published Date: 2 December 2008

Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism

Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal

Vascular Health and Risk Management 2009, 5:9-12

Published Date: 24 November 2008

Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes

Rajan Sharma, Denis Pellerin

Vascular Health and Risk Management 2009, 5:1-7

Published Date: 24 November 2008